ProQR Therapeutics shares are trading higher after Evercore ISI Group maintained its Outperform rating on the stock and raised its price tar

ProQR Therapeutics shares are trading higher after Evercore ISI Group maintained its Outperform rating on the stock and raised its price target from $5 to $6.